LONDON, Nov. 19, 2018 /PRNewswire/ -- The Global Needle Free Injection System Market size is expected to reach $25 billion by 2024, rising at a market growth of 16.3% CAGR during the forecast period. Needle-free injections are devices that are used for administering liquid formulations, drugs, and vaccines, without piercing the skin with a conventional needle. As these systems improve the immune response to vaccines, eliminate risks of needles, and reduce healthcare costs, the demand for these systems has witnessed unprecedented demand. However, lack of skilled professionals and the restricted use of needle-free injection systems for intravenous administration would be factors that hamper the growth of this market.Download the full report: https://www.reportbuyer.com/product/5622529
Growing cases of diabetes has driven the demand for needle-free insulin delivery devices globally. According to the Centers for Disease Control and Prevention, in 2015, approximately 30.3 million people or 9.4% of the total population of the U.S. suffered from diabetes. In addition, according to the Diabetes UK, in 2016, approximately 3.6 million people were diagnosed of diabetes in the UK. Therefore, growing diabetics would propel the market growth.On the basis of Product, the market is segmented into Prefilled Needle-Free Injectors and Fillable Needle-Free Injectors. Technology is categorized into Jet-Based Needle-Free Injectors, Spring-Based Needle-Free Injectors, Laser-Powered Needle-Free Injectors, and Vibration-Based Needle-Free Injectors. On the basis of Type, the market is segmented into Liquid-Based Needle Free Injectors, Projectile/Depot-Based Needle-Free Injectors, and Powder-Based Needle Free Injectors. By Site of delivery, the market is divided into Subcutaneous Injectors, Intramuscular Injectors, and Intradermal Injectors. Usability has been segmented into Reusable Needle-Free Injectors and Disposable Needle-Free Injectors. On the basis of Application, the market is categorized into Vaccine Delivery, Insulin Delivery, Pain Management, and Other Applications. The End Users covered under the report are Hospitals and Clinics, Home Care Settings, Research Laboratories, and Others. Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa.The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Endo International PLC, Antares Pharma, Inc, Pharmajet, Medical International Technology, Inc. (MIT), National Medical Product Inc, Valeritas Inc, European Pharma Group BV, Portal Instruments, Injex Pharma AG, Bioject Medical Technologies Inc.Download the full report: https://www.reportbuyer.com/product/5622529
About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers For more information: Sarah Smith
Research Advisor at Reportbuyer.com Email: [email protected]
Tel: +1 (718) 213 4904 Website: www.reportbuyer.com
Advertisement
View original content:http://www.prnewswire.com/news-releases/the-global-needle-free-injection-system-market-size-is-expected-to-reach-25-billion-by-2024--rising-at-a-market-growth-of-16-3-cagr-during-the-forecast-period-300752898.html
SOURCE ReportBuyer
